Cargando…
High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma
BACKGROUND: The validation of novel prognostic indicators is of greatest interest for the management of esophageal adenocarcinoma (Barrett's cancer), particularly for non-metastasized (stage I-IIA) disease. The prognostic role of tumor infiltrating T-lymphocytes (TILs) in Barrett's cancer...
Autores principales: | Rauser, Sandra, Langer, Rupert, Tschernitz, Sebastian, Gais, Peter, Jütting, Uta, Feith, Marcus, Höfler, Heinz, Walch, Axel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988756/ https://www.ncbi.nlm.nih.gov/pubmed/21054833 http://dx.doi.org/10.1186/1471-2407-10-608 |
Ejemplares similares
-
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy
por: Aichler, Michaela, et al.
Publicado: (2014) -
Diagnosis and Prognosis of Neuroendocrine Tumours of the Lung by Means of High Resolution Image Analysis
por: Jütting, Uta, et al.
Publicado: (1999) -
Relevance of Chromatin Features in the Progression of Esophageal Epithelial Severe Dysplasia
por: Gao, Feng, et al.
Publicado: (1997) -
MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology
por: Walch, Axel, et al.
Publicado: (2008) -
Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
por: Walch, Axel, et al.
Publicado: (2000)